Elan Corporation, plcDublin Ireland
Company Description
Elan has brain and nerve conditions on its mind. The biotech company is focused on the development of pharmaceuticals for neurological and autoimmune disorders. Its product offerings include anti-infectives and treatments for degenerative diseases. Elan's future fortunes rely largely on the success of beleaguered multiple sclerosis (MS) and Crohn's disease therapy Tysabri, a monoclonal antibody (single-source protein) therapy it co-developed with
| Treasury Building, Lower Grand Canal St. | Phone: +353-1-709-4000 | http://www.elan.com |
| Dublin | Fax: +353-1-709-4700 | 
Map This Company |
| Ireland |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Elan Corporation, plc Rankings
Executives
| 28 executives listed for Elan Corporation, plc's Dublin, Ireland location. | ||
| Chairman | Robert Ingram | |
|---|---|---|
| CEO and Director | G. Kelly Martin | |
| President | Carlos Paya | |
Financials
| Company Type | Public - NYSE: ELN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 412 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Elan Corporation, plc now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
